CRL · 10-Q · 2026Q3 · Full report

Liquidity and Debt Position

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-11-04 · Importance 66 · Surprise 40

Cash and cash equivalents totaled $200.4 million at September 26, 2026, down from $213.8 million at December 27, 2025; $195.8 million was held in non-U.S. entities. Total debt outstanding increased to $2.443 billion from $2.117 billion, including $943.2 million drawn on the revolving facility and three $500 million senior-note issues due in 2028, 2029, and 2031. The revolving facility provides up to $2.0 billion of multi-currency credit, matures in December 2029, and has no scheduled payment before maturity. The company reported $21.7 million of outstanding letters of credit at September 26, 2026.

Key facts

• The Credit Facility provides up to $2.0 billion of multicurrency revolving credit and matures in December 2029, with no required scheduled payments before maturity. source
• The Company’s Credit Facility and Senior Notes totaled $2,443.2 million outstanding at September 26, 2026, including $943.2 million on the revolving facility and $1.5 billion of Senior Notes. source
• Cash and cash equivalents totaled $200.4 million at September 26, 2026, including $4.5 million held in U.S. entities and $195.8 million held in non-U.S. entities. source
• The Company stated that existing funds, cash generated from operations, and access to financing resources were sufficient to fund operations for the foreseeable future based on its current business plan. source